136 related articles for article (PubMed ID: 22082680)
1. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
Galvani S; Trayssac M; Augé N; Thiers JC; Calise D; Krell HW; Sallusto F; Kamar N; Rostaing L; Thomsen M; Nègre-Salvayre A; Salvayre R
Circulation; 2011 Dec; 124(24):2725-34. PubMed ID: 22082680
[TBL] [Abstract][Full Text] [Related]
2. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies.
Trayssac M; Nègre-Salvayre A; Thomsen M
Hum Immunol; 2012 Dec; 73(12):1253-60. PubMed ID: 22789624
[TBL] [Abstract][Full Text] [Related]
4. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
Tellier E; Nègre-Salvayre A; Bocquet B; Itohara S; Hannun YA; Salvayre R; Augé N
Mol Cell Biol; 2007 Apr; 27(8):2997-3007. PubMed ID: 17283058
[TBL] [Abstract][Full Text] [Related]
5. Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody.
Trayssac M; Galvani S; Augé N; Sabbadini R; Calise D; Mucher E; Sallusto F; Thomsen M; Salvayre R; Nègre-Salvayre A
Am J Transplant; 2015 Aug; 15(8):2050-61. PubMed ID: 25930666
[TBL] [Abstract][Full Text] [Related]
6. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL.
Camaré C; Augé N; Pucelle M; Saint-Lebes B; Grazide MH; Nègre-Salvayre A; Salvayre R
Free Radic Biol Med; 2016 Apr; 93():204-16. PubMed ID: 26855418
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase.
Kolmakova A; Kwiterovich P; Virgil D; Alaupovic P; Knight-Gibson C; Martin SF; Chatterjee S
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):264-9. PubMed ID: 14670935
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
Maupas-Schwalm F; Bedel A; Augé N; Grazide MH; Mucher E; Thiers JC; Salvayre R; Nègre-Salvayre A
Cell Signal; 2009 Dec; 21(12):1925-34. PubMed ID: 19735728
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
[TBL] [Abstract][Full Text] [Related]
10. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
[TBL] [Abstract][Full Text] [Related]
11. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.
Peterson M; Porter KE; Loftus IM; Thompson MM; London NJ
Eur J Vasc Endovasc Surg; 2000 May; 19(5):461-7. PubMed ID: 10828225
[TBL] [Abstract][Full Text] [Related]
12. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
Dwivedi A; Slater SC; George SJ
Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice.
Johnson JL; Dwivedi A; Somerville M; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):e35-44. PubMed ID: 21719762
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of immunodeficient SCID/beige mice with human cells: applications in preclinical studies.
Thomsen M; Galvani S; Canivet C; Kamar N; Böhler T
Toxicology; 2008 Apr; 246(1):18-23. PubMed ID: 18055093
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia.
Kuzuya M; Kanda S; Sasaki T; Tamaya-Mori N; Cheng XW; Itoh T; Itohara S; Iguchi A
Circulation; 2003 Sep; 108(11):1375-81. PubMed ID: 12939223
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase.
Ohanian J; Forman SP; Katzenberg G; Ohanian V
J Vasc Res; 2012; 49(4):353-62. PubMed ID: 22627111
[TBL] [Abstract][Full Text] [Related]
17. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
[TBL] [Abstract][Full Text] [Related]
18. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
19. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
20. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha.
Bian H; Reed EF
J Immunol; 1999 Jul; 163(2):1010-8. PubMed ID: 10395699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
